Detalles de la búsqueda
1.
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.
Cell
; 183(3): 786-801.e19, 2020 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125893
2.
Integrated Single-Cell (Phospho-)Protein and RNA Detection Uncovers Phenotypic Characteristics and Active Signal Transduction of Human Antibody-Secreting Cells.
Mol Cell Proteomics
; 22(2): 100492, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623694
3.
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.
Blood
; 127(25): 3225-36, 2016 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127303
4.
Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury.
Toxicol Appl Pharmacol
; 313: 88-96, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27760303
5.
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction.
Proc Natl Acad Sci U S A
; 108(45): 18342-7, 2011 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22042861
6.
Cancer therapy with antibodies.
Nat Rev Cancer
; 24(6): 399-426, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740967
7.
Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury.
J Pharmacol Exp Ther
; 344(1): 2-7, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23131595
8.
Epitope mapping of monoclonal antibodies: a comprehensive comparison of different technologies.
MAbs
; 15(1): 2285285, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010385
9.
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.
Mol Ther Nucleic Acids
; 33: 599-616, 2023 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37637207
10.
Shortened Hinge Design of Fab x sdAb-Fc Bispecific Antibodies Enhances Redirected T-Cell Killing of Tumor Cells.
Biomolecules
; 12(10)2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291540
11.
Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine Receptors.
Front Med (Lausanne)
; 9: 931293, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35966871
12.
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.
J Immunother Cancer
; 10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100308
13.
Purification of murine immunoglobulin E (IgE) by thiophilic interaction chromatography (TIC).
J Immunol Methods
; 489: 112914, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197470
14.
Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies.
J Immunol Methods
; 499: 113173, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699840
15.
Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.
BMC Genomics
; 11: 359, 2010 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20525385
16.
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy.
J Cancer Res Clin Oncol
; 146(12): 3111-3122, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989604
17.
A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
J Immunol Methods
; 483: 112811, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32569598
18.
Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab.
Mol Cancer Ther
; 19(6): 1298-1307, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32229606
19.
Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy.
Oncoimmunology
; 8(11): e1648171, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646095
20.
APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications.
Leukemia
; 33(2): 426-438, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30135465